CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Shire Orphan Therapies LLC v. InnoPharma Inc.

1:16-cv-00456

Overview

Case Number 1:16-cv-00456
Filing Date 2016-06-17
Status Terminated
Termination Date 2016-12-12
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

InnoPharma Inc. Operating Company

Represented By

4 Attorneys Listed

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Yusuf Esat

Email: yesat@jenner.com

Sara Tonnies Horton

Email: shorton@willkie.com

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Plaintiff

Sanofi-Aventis Deutschland GmbH NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Shire Orphan Therapies LLC Operating Company

Represented By

6 Attorneys Listed

Sandra Kuzmich

Email: skuzmich@haugpartners.com

Laura A. Fanelli

UNDELIVERABLE EMAIL 7/7/17

Laura A. Chubb

Email: lchubb@haugpartners.com

Edgar H. Haug

Email: ehaug@haugpartners.com

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 17 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (17): πŸ‡©πŸ‡ͺ Germany πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5648333
Peptides having bradykinin antagonist action
Filed: 1995-06-07
Issued: 1997-07-15
Expired (Term Ended) +1499d PTA
Expires: 2019-07-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1499 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

0

Motions by Category

Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending
ORAL ORDER SCHEDULING A STATUS TELECONFERENCE: A Teleconference to discuss the schedule (specifically, the Markman Hearing and Claim Construction deadlines) in ...
Entry #β€” • 2016-09-22

Docket Entries

(50 total)
Pleading / Complaint

COMPLAINT filed against InnoPharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1949108.) - filed by Shire Orphan Therapies LLC, Sanofi-Aventis Deutschland GmbH.(Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet(aah) (Entered: 06/17/2016)

Entry #1 • 2016-06-17
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction.(aah) (Entered: 06/17/2016)

Entry #2 • 2016-06-17
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/11/2016. Date of Expiration of Patent: 7/15/2019.Thirty Month Stay Deadline: 2/25/2019.(aah) (Entered: 06/17/2016)

Entry #3 • 2016-06-17
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,648,333;(aah) (Entered: 06/17/2016)

Entry #4 • 2016-06-17
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent American Depositary Receipts for Sanofi-Aventis Deutschland GmbH; Corporate Parent Shire PLC for Shire Orphan Therapies LLC filed by Sanofi-Aventis Deutschland GmbH, Shire Orphan Therapies LLC.(aah) (Entered: 06/17/2016)

Entry #5 • 2016-06-17
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc